This Case Study demonstrates the necessity of exploring alternative manufacturing methods to address production obstacles that may arise in the supply chain for cell and gene therapy products due to their distinctive availability challenges.

The critical stages of cell and gene therapy manufacturing need an established and robust process to address production obstacles highlighted by a global supply chain crisis. ScaleReady’s G-Rex platform, utilizing closed system bioreactors, offers a more feasible process for producing high quality cells. This reduction in raw material usage and operator effort contributes to enhanced efficiency and cost effectiveness in cell therapy production.  

In this Case Study, the team at ScaleReady demonstrate a solution for expanding the capabilities of scalability during the manufacturing process for cell and gene therapy. 

Download the full Case Study to find out more.

This Case Study has been produced in partnership with ScaleReady.